JERSEY CITY, N.J, March 13, 2024 /PRNewswire/ — InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Lipid Nanoparticle Raw Materials Market– By Application (Therapeutics and Research), By Product (Ionizable Lipids, Reagents, Others), By Disease Indication (Cancer, Infectious Diseases, Blood Diseases, Others), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”

According to the latest research by InsightAce Analytic, the Global Lipid Nanoparticle Raw Materials Market is valued at US$ 230.23 Mn in 2023, and it is expected to reach US$ 356.05 Mn by 2031, with a CAGR of 5.80% during the forecast period of 2024-2031.

Lipid Nanoparticle Raw Materials Market Report Scope:

 

Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/2367 

The various building blocks of lipid nanoparticles are lipids, stabilizers, and occasionally targeting ligands. Lipids that are frequently used are phospholipids, which include cholesterol and phosphatidylcholine.

The rise in the market is ascribed to various factors, including the growing need for medications that employ lipid nanoparticles as delivery vehicles, the increasing occurrence of chronic illnesses like cancer, cardiovascular diseases, and autoimmune disorders, and technological developments.

Additionally, it is anticipated that the growing number of partnerships and joint ventures amongst industry participants will favorably affect market expansion.

List of Prominent Players in the Lipid Nanoparticle Raw Materials Market:

• Echelon Biosciences
• BroadPharm
• Biopharma PEG Scientific Inc.
• NOF AMERICA CORPORATION
• CordenPharma International
• Merck KGaA
• Avanti Polar Lipids
• Tebubio
• Creative Biolabs
• Polysciences, Inc.
• Precision NanoSystems (Cytiva)
• Evonik Industries AG
• Nippon Fine Chemical
• Lipoid GmbH
• CLARIANT

Market Dynamics:

Drivers-

Support from the government is essential for R&D projects aimed at creating novel lipid nanoparticle-based products, such as medication delivery methods for a range of therapeutic uses. Furthermore, the market’s expansion is propelled by leading players’ increasing investment in research and development capabilities, which in turn fosters technological improvements, expands market prospects, and stimulates innovation.

For instance, Evonik stated in June 2022 that it would build a new, large-scale pharmaceutical lipid production facility in the United States. In addition, the need for LNP raw materials in the biotechnology and pharmaceutical sectors is greatly impacted by the rising incidence of cancer.

Challenges:

The production of lipid nanoparticles is an intricate and costly procedure requiring a multidisciplinary team of experts. As a result, pharmaceutical producers depend more on contract manufacturing organizations (CMOs) that have specialized machinery and knowledge to handle the difficulties associated with normal operations and technological issues. In addition, a number of rules have been introduced to monitor the efficacy and quality of medications in light of the pharmaceutical industry’s global expansion.

Furthermore, a several nations’ rigorous laws limited the amount of money that could be invested in research and development to create and market sophisticated medications that use lipid nanoparticle raw materials.

Regional Trends:

The North America lipid nanoparticle raw materials market is expected to register major market share in terms of revenue and projected to grow at a high CAGR in the near future. The North American pharmaceutical and biotechnology industries are strong, which supports the market’s expansion.

Lipid nanoparticle-based drug delivery systems are in high demand due to the significant investments made in research and development by pharmaceutical and biotech businesses in the United States and Canada.

There are now more prospects for lipid nanoparticle-based delivery methods in North America due to the trend toward biologics and gene therapy products. Besides, Asia Pacific is anticipated to be the fastest growing region in the market. The area’s economy is expanding quickly, which is driving up the cost of healthcare and investments in medical R&D.

Lipid nanoparticles are one of the modern drug delivery technologies that are in high demand due to expanding healthcare services and improved infrastructure, which is propelling market expansion. 

Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2367 

Recent Developments:

• February 2024: University of Pennsylvania researchers in the United States have developed a unique high-throughput screening tool designed for evaluating mRNA enclosed in lipid nanoparticles. With the help of this cutting-edge platform, large libraries of LNPs intended for brain targeting may be quickly screened. Its application accelerates the development of gene editing treatments by assessing and fine-tuning LNPs meant for brain delivery.
• July 2023: A formulation technique from Cytiva has been made available to enable the seamless production of lipid nanoparticle medications at both the clinical and commercial stages. By streamlining the procedure, this method makes it possible to produce lipid nanoparticle-based drugs effectively and completely, from development to commercialization.

Segmentation of Lipid Nanoparticle Raw Materials Market-

By Application

• Therapeutics
• Research

By Product

• Ionizable Lipids
  • PEGylated Lipids
  • Sterol Lipids
  • Neutral Phospholipids
•  Kits
• Reagents
• Other Raw Materials

By Disease Indication

• Cancer
• Infectious Diseases
• Blood Diseases
• Others

By End-use

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others

By Region

North America–

• The US
• Canada
• Mexico

Europe–

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific–

• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America–

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa–

• GCC Countries
• South Africa
• Rest of Middle East and Africa

For More Customization @ https://www.insightaceanalytic.com/customisation/2367

Why should buy this report:

• To receive a comprehensive analysis of the prospects for global Lipid Nanoparticle Raw Materials market Lipid Nanoparticle Raw Materials
• To receive industry overview and future trends of global Lipid Nanoparticle Raw Materials market
• To analyze the Lipid Nanoparticle Raw Materials market drivers and challenges
• To get information on the Lipid Nanoparticle Raw Materials market size value (US$ Mn) forecast till 2031
• Major Investments, Mergers & Acquisition in global Lipid Nanoparticle Raw Materials market industry

Other Related Reports Published by InsightAce Analytic:

Lipid Nanoparticles (LNPs) CDMO Market 

Nanoparticle Formulation Market

Lipid Nanodiscs Market

Sample Preparation Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact US:

InsightAce Analytic Pvt. Ltd.

Tel.: + +1 551 226 6109

Email: [email protected]

Site Visit: www.insightaceanalytic.com

Follow Us on LinkedIn @ bit.ly/2tBXsgS

Follow Us On Facebook @ bit.ly/2H9jnDZ

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg 

 

View original content:https://www.prnewswire.co.uk/news-releases/lipid-nanoparticle-raw-materials-market-worth-356-05-mn-by-2031—exclusive-report-by-insightace-analytic-pvt-ltd-302087916.html

Featured image: Megapixl © Zuzuan

Disclaimer